Skip to main content

Clinical parameters and inflammatory biomarkers among patients with multibracket appliances: a prospective clinical trial

Abstract

Background

Aim of the presented study was to investigate changes in clinical parameters and active matrix metalloproteinase-8 (aMMP-8) levels in gingival crevicular fluid of patients before and during treatment with multibrackets appliances.

Methods

Fifty-five adolescents scheduled for the treatment were included. Clinical parameters and subgingival samples were obtained at six time points: 1 week before appliance insertion (T0), 3 (T1), 6 (T2) weeks, 3 (T3), 6 (T4) months, and 1 year (T5) after that. Gingival index and plaque index were assessed to evaluated changes on the clinical status. Subgingival samples were collected to analyze changes in aMMP-8.

Results

Scores for gingival and plaque index increased after bracket insertion. The gingival index increased from T2 (p < 0.05) until T5 (p < 0.0001). Plaque index also increased, reaching its maximum peak at T3 (p < 0.05). Moreover, an increase of aMMP-8 levels (p < 0.05) was noted. There was no significant between upper and lower jaws.

Conclusions

Treatment with multibracket appliances in adolescents favors dental plaque accumulation and may transitionally increase gingival and plaque index and aMMP-8 levels leading to gingival inflammation, even 1 year after therapy began.

Trial registration

This study was approved by the Ethics Committee of the dental medical association Rheiland-Pfalz, Germany (process no. 837.340.12 (8441-F)), and followed the guidelines of Good Clinical Practices.

Peer Review reports

Background

Dental and skeletal malocclusions can have a negative impact on quality of life by interfering with the patient´s aesthetics, social interaction, and psychological well-being [1,2,3,4,5]. Moreover, it can affect functions of the stomatognathic system such as breathing, chewing, and swallowing. Due to these reasons, the malocclusion should be treated [4, 6,7,8].

Orthodontic therapy with multibracket appliance (MBA) is a widely used method for the treatment of malocclusions. However, the components of this appliance such as brackets, arches, ligaments, and tubes make oral hygiene difficult, affecting oral health by the increased accumulation of biofilm around the retentive structures [9, 10].

Thus, the high number of retention surfaces for biofilm together with poor oral hygiene can contribute to the development of white spot lesion [11,12,13], gingivitis [14,15,16,17], or even periodontal attachment loss [18,19,20,21,22]. Furthermore, it can lead to pathogenic bacterial colonization [23,24,25,26,27,28] and increased levels of matrix metalloproteinases (MMPs) found in gingival crevicular fluid (GCF), salivary fluid, and gingival tissues, triggering a periodontal disease [29, 30].

MMPs are proteolytic enzymes involved in the degradation and remodeling process of the extracellular matrix, both in physiological and pathological situations. MMP8 is considered the most significant collagenase found in CGF and is present in an active and latent forms. In its activated form, aMMP-8 decomposes periodontal tissue collagen leading to alveolar bone destruction [31,32,33].

Studies have shown that MMP8 plays an important role in the periodontal remodeling process during orthodontic movement [34,35,36]. MMP8 levels in GCF were found elevated after 4–8 h of orthodontic force application, this suggests that cells of periodontum are upregulated to express MMP-8, and its enhancement and activation indicates periodontal remodeling due to orthodontic force [37].

Interestingly, aMMP-8 concentration assessment in GCF or salivary fluid allows much earlier, non-invasive and more objective method to diagnose acute inflammatory events prior to clinical manifestations. Because of that, it has been used as an inflammatory and prevention biomarker in periodontal disease diagnosis [30, 38,39,40,41,42,43,44,45,46,47,48,49,50,51] and also to detect peri-implantitis lesions [42, 49, 51,52,53,54,55,56].

Traditional periodontal diagnostic indices such as clinical attachment level, bleeding on probing, GI [14, 57, 58], PI [59,60,61,62] or x-rays are only visible after the presence of inflammation or biofilm formation, or even after the presence of partially irreversible periodontal damage.

Since MBA treatment can negatively affect patients' oral health, the present study aimed to evaluate clinical aspects, using GI and PI, and levels of aMMP8 in GCF of MBA patients at different time points up to 1 year after MBA placement.

Materials and methods

Subjects

This prospective study was conducted at the Department of Orthodontics and Dentofacial Orthopedics, University Medical Center of the Johannes Gutenberg, Mainz, Germany. From a clinic´s currently patients list, 80 patients were blindly selected and asked by the study examiner if they wished to participate in this study either by telephone or personally when the patient came to the clinic for the first consultation. Fifty-five subjects, 30 females and 25 males aged between 12 to 17 years (mean age 13.81 ± 1.3) were then included in the study, which was performed between August 2013 and April 2017.

Inclusion criteria were a malocclusion with an indication for therapy with fixed orthodontic appliance in the upper jaw (UPJ) and lower jaw (LOJ); good general and periodontal health; a minimum of 16 natural teeth, including 8 anterior teeth. Subjects were exclude if they had a previous orthodontic treatment; more than 3 carious defects; periodontal disease; antibiotic intake or a professional dental cleaning two weeks before study start; patients with any kind of syndrome (Down-, Crouzon-, Apert-, Goldenhar-, Marfan-, Franchescetti-, Pierre-Robin-Syndrome); craniofacial anomalies such as cleft lip and palate; diabetes mellitus; allergies to dyes/colorants; pregnancy. All volunteers and their guardians were informed about the study procedures and signed a declaration of consent prior to participation.

Overall study design

The entire study consisted of six time points (T): Baseline (T0): 1 week before bracket bonding (BB); T1: 3 weeks, T2: 6 weeks, T3: 3 months, T4: 6 months and T5: 1 year after BB. The subjects were instructed to brush their teeth before 8:00 AM on the study day and also not to eat or drink (except water) 2 h before the visit. Table 1 summarizes the overall study design.

Table 1 Study schedule by procedures according to different time points

At each visit a visual examination was performed to inspect the oral cavity. Teeth, gingival, palate, labial mucosa, tongue, mouth floor, and lips were examined and abnormal findings were noted. Afterwards, GI and PI were conducted. Subsequently, subgingival samples were collected.

BB occurred one week after T0. A professional dental cleaning was performed and conventional metallic brackets—nickel-free, system-slot 0.022″ (Micro Sprint Brackets—Forestadent®; Pforzheim, Germany) were bonded on the buccal teeth surfaces (except molars) in UPJ and LOJ with Transbond XT (3 M ESPE).

Clinical procedures

Gingival index

The gingival color assessment, consistency, inflammation, and bleeding on probing was performed using the GI according to Löe and Silness [14]. All teeth except the molars were assessed. A modification was made to the GI regarding the number of observed areas, and instead of four gingival units (buccal, lingual, mesial and distal), each tooth was divided into six gingival areas: distobuccal, buccal, mesiobuccal, mesiolingual (or mesiopalatinal), lingual (or palatinal) and distolingual (or distopalatinal). Teeth and gingiva were gently dried with air before scoring to provide proper visibility. Then, without pressure, the periodontal probe tip was inserted about 1 mm into the gingival margin. Each of tooth surfaces received a score: 0: normal gingiva; 1: Mild inflammation – slight change in color, slight edema; no bleeding on probing; 2: Moderate inflammation – redness, edema, and glazing; bleeding on probing; 3: Moderate inflammation – redness, edema, and glazing; bleeding on probing. An index for the entire mouth was determined by dividing the total score by the number of surfaces examined.

Plaque index

The Turesky Modification of the Quigley-Hein PI [63] was performed by an experienced examiner to assess the plaque level on the buccal and lingual/palatinal surfaces of all teeth, except molars, crowns, and surfaces with cervical restoration. All teeth were stained using a foam pellet (Erkodent®, Pfalzgrafenweiler, Germany) and a plaque disclosing agent (Mira-2-Ton, Hager Werken, Duisburg, Germany). Subjects rinsed the mouth thoroughly with water and supragingival plaque was scored using a 0–5 Scale: 0: absence of plaque; 1: isolated plaque spots on the cervical margin; 2: a slim continuous layer of plaque (up to 1 mm) at the cervical margin; 3: a layer of plaque thicker than 1 mm; 4: plaque covering at least one-third of the side of the crowm of the tooth; 5: plaque covering two-thirds of the side of the crowm of the tooth [63]. To calculate whole mouth plaque level, the total score was divided by the number of examined teeth.

Subgingival samples – concentration of aMMP-8

Subgingival samples were taken after the participants had brushed their teeth’s to remove supragingival plaque, using a sterilized paper strip (GCF collection Strips – dentognostics GmBH; Jena, Germany) from the distal approximal space of the Ramfjord teeth [16, 12, 24, 36, 32, 44] [64, 65]. If a Ramfjord tooth was missing, a substitute tooth (teeth number: 17, 11, 25, 37, 31, 45) was chosen [66].The area was gently dried and with cotton rolls (Roeko-Luna; Coltène-Whaledent Gmbh, Langenau, Germany) isolated from oral fluid to avoid contamination. GCF samples collected as pool from the UPJ and the LOJ. All samples were send to Bioscientia Laboratory (Institut für Medizinische Diagnostic GmbH, Berlin) and a quantitatively analyzed for aMMP-8 using an enzyme-linked immunosorbent assay (ELISA—dentoELISA aMMP-8, dentognostics GmbH, Jena, Germany) was at these lab performed. The degree values of aMMP-8 levels (nanograms per milliliter (ng/ml)) with a cut-off 20 ng/ml for periodontitis were as following: ≤ 10 ng/ml: healthy; < 20 ng/ml: slow rate of progression; ≥ 20 ng/ml: moderate rate of progression [42, 67,68,69].

Statistical analysis

All statistical analyses were performed using SPSS (IBM® SPSS® Statistics, Version 23, IBM Corporation, Armonk, USA, © 1989, 2015). Mean value, standard deviation, interquartile distance, and median were determined for the assessment and evaluation of the GI, PI, and aMMP-8 levels values at the respective time point. Differences between UPJ and LOJ were assessed using paired t-tests comparing values at follow-up visits to baseline values. The significance level was chosen as α = 0.05. As numerous comparisons were performed and focus was on detecting possible changes and associations no formal adjustment for multiple testing was performed. Therefore, only the local significance level was controlled and the probability of obtaining at least one false positive result is substantially higher than 5%.

Results

Subjects

Fifty five adolescents (45.5% male and 54.5% female), 98.2% Caucasians and 1.8% Asian, were screened and 50 completed the roll study. One subject had the MBA removed before 1 year of therapy and missed the last time point. Two subjects moved to another city and therefore could no longer participate in this trial. And two other subjects showed a lack of compliance and both were excluded after the 5th time point.

GI, PI values and aMMP8 levels

GI, PI values and aMMP8 levels are presented first as an index in UPJ and LOJ at different time points, and second as a comparison between UPJ and LOJ.

GI total gradually increased (p < 0.0001) after T2 until T5, when it had reached its maximum peak signaling a tendency to gingival inflammation even 1 year after treatment began (Fig. 1).

Fig. 1
figure 1

Boxplot diagram showing GI for the entire UPJ and LOJ at different time points. TO: 1 week before bracket bonding; T1: 3 weeks after bracket bonding; T2: 6 weeks after bracket bonding; T3: 3 months after bracket bonding; T4: 6 months after bracket bonding; T5: 1 year after bracket bonding GI Scores: 0: normal gingiva; 1: Mild inflammation; 2: Moderate inflammation; 2,5: severe inflammation

PI total values as well GI values continued to increase after appliance installation, until T3, when it reached its maximum peak (p < 0.05). Then, there was a small decrease at T4 followed by an increase at T5 (p < 0.05) (Fig. 2).

Fig. 2
figure 2

Boxplot diagram showing the PI for the UPJ and LOJ at different time points.TO: 1 week before bracket bonding; T1: 3 weeks after bracket bonding; T2: 6 weeks after bracket bonding; T3: 3 months after bracket bonding; T4: 6 months after bracket bonding; T5: 1 year after bracket bonding. PI Scores: 0: no plaque; 1: single plaque areas; 2: plaque lines; 3: plaque extension up to 1/3 of tooth surface; 4 plaque extension up to 2/3 of tooth; 5: plaque extension more than 2/3 of the tooth surface

The levels of aMMP-8 in GCF increased significantly at T1, T3, and T5, when reached its maximum peak, signalizing a low degree of inflammation (Fig. 3). Table 2 summarizes the total GI, PI, and the concentration of aMMP8 at different appointments.

Fig. 3
figure 3

Boxplot showing the aMMP-8 levels in UPJ and LOJ at different time points. TO: 1 week before bracket bonding; T1: 3 weeks after bracket bonding; T2: 6 weeks after bracket bonding; T3: 3 months after bracket bonding; T4: 6 months after bracket bonding; T5: 1 year after bracket bonding aMMP8 Scores: ≤ 10 ng/ml: healthy; < 20 ng/ml: slow rate of progression; ≥ 20 ng/ml: moderate rate of progression

Table 2 Statistical parameters of the total GI, PI and aMMP8 levels (ng/ml) at different time points

There was no statistically significant difference between UPJ and LOJ regarding GI, PI, and aMMP8. Table 3 provides additional details about the comparison these parameters in UPJ and LOJ.

Table 3 GI; PI; aMMP8 levels (ng/ml) – Comparison between upper and lower jaw

For statistical analysis was used the program SPSS (IBM® SPSS® Statistics, Version 23, IBM Corporation, Armonk, USA, © 1989, 2015). Changes of GI, PI, and aMMP-8 over time and differences between upper and lower jaw were assessed using paired t-tests comparing values at follow-up visits to baseline values. The significance level was chosen as α = 0.05. As numerous comparisons were performed and the focus was on detecting possible changes and associations no formal adjustment for multiple testing was performed. Therefore, only the local significance level was controlled and the probability of obtaining at least one false positive result is substantially higher than 5%.

Discussion

Periodontal inflammation and caries are the main concern during fixed appliance treatment. The present study reports a significant increase in GI and PI values as well as aMMP8 levels in adolescents after MBA insertion, even up to 1 year after treatment begin. Thereby suggesting that plaque accumulation could be the causative factor for the gingivitis reported in these patients. Increased GI and PI values in the first therapy months may be due to patient's unfamiliarity with the appliance and difficulty in maintaining a proper oral hygiene. The reduction noted in these values after 6 months of treatment supports the fact that dental alignment allows the patient to achieve a good gingival condition around previously misaligned teeth [70]. However, the long orthodontic treatment duration can lead to a lack of patient motivation to perform good oral hygiene, justifying the observed increase in PI values 1 year post fixed appliance insertion.

Our results were in accordance with Naranjo et al. [17] and Guo et al. [10], regarding the elevated GI and PI values 3 months after MBA insertion. Ristic et al. [27, 28] also reported an increase after 3 months of therapy followed by a decrease 6 months later. Liu et al. [71] reported a significant decrease of these indices after 1 week of appliance removal, returning to pre-treatment values. Kim et al. [26] also related a decrease in GI and PI values 6 months after therapy end. A systematic review conducted by Cerroni et al. suggests that there is moderate scientific evidence that a fixed appliance negatively influences periodontal status [72]. On the other hand, Gomes and co-workers [73] stated that orthodontic appliances use is not necessarily related to periodontal conditions aggravation, but rather to each person´s susceptibility to periodontal disease.

Nonetheless, the majority published studies in the literature have a patient follow-up up to 3 or 6 months after brackets placement or post-appliance removal and with a small sample size. In contrast, our study accompanied 55 patients until 6 months and 50 subjects up to 1 year of MBA treatment. More long-term studies are necessary to be conduct on a wider sample size containing a control group to evaluate MBA effects on periodontium after years of treatment. Hence, our findings endorse previous reports showing an existing correlation between GI and PI values before and during orthodontic treatment. Accordingly, it can be suggested that plaque accumulation favored by brackets and archwires can cause gingival inflammation. Moreover, it is implied that MBA induces gingival inflammation without damaging the dental support tissues.

Though, a present study´s limitation is regarding GI and PI analysis. Both indices express the total buccal and palatinal/lingual surfaces sum values. It would be interesting to compare these two surfaces, once the brackets were bonded on the buccal teeth surface. A second point which should be considered is GI and PI distribution between anterior and posterior segments.

Regarding to aMMP8, the majority studies found in the literature associate the high presence of MMP-8 in GCF of orthodontic patients with periodontal ligament remodeling process [74, 75] and with pain mentioned by some patients during the first hours/days after appliance placement [76]. Surlin et al. [34] reported an increase in MMP-8 concentration in the first 4–8 h after orthodontic appliance placement followed by a decrease to initial levels. Some subjects developed gingival overgrowth (GO) during orthodontic treatment even in bacterial plaque absence. Interestingly, in these patients MMP-8 levels continued to increase until GO appearance. Furthermore, some patients presented GO in combination with inflammation and in these cases, MMP-8 concentration was higher than in GO cases without inflammation. In this way, the authors suggest that MMP-8 may be a possible biomarker for GO beginning [51].

Our study´s novelty was the use of aMMP-8 as periodontal biomarker in patients undergoing orthodontic treatment. It provides original evidence that 3 weeks after brackets placement there was a significant increase of aMMP-8 levels, which remained elevated even 1 year after treatment began, suggesting an inflammations tendency. aMMP8 high rates evidenced in this study agree with the high GI and PI scores.

Conclusion

In summary, it can be concluded that the therapy with MBA may transitionally increase gingivitis, plaque accumulation, and aMMP-8 levels even 1 year after the beginning of therapy, occasionally leading to gingival inflammation but without destruction of periodontal supporting tissue. No significant differences were found between UPJ and LOJ values.

Since changes in clinical parameters and GCF increase the risk of periodontal tissue inflammation, proper oral hygiene instructions should be given to orthodontic patients in order to provide good oral hygiene, constant motivation, and continuous plaque control during the entire treatment. Long-term studies are needed to explore the impact of bacterial colonization on periodontal conditions and clinical aspects during the years of orthodontic treatment with fixed appliance and after its removal.

Availability of data and materials

The datasets used and/or analyzed during the current study may be available from the corresponding author on reasonable request.

Abbreviations

MMPs:

Matrix metalloproteinase

aMMP8:

Active matrix metalloproteinase-8

MBA:

Multibracket appliance

GCF:

Gingival crevicular fluid

GI:

Gingival index

PI:

Plaque index

UPJ:

Upper jaw

LOJ:

Lower jaw

BB:

Bracket bonding

T:

Time points

References

  1. Sun L, Wong HM, McGrath CPJ. Association Between the Severity of Malocclusion, Assessed by Occlusal Indices, and Oral Health Related Quality of Life: A Systematic Review and Meta-Analysis. Oral Health Prev Dent. 2018;16(3):211–23.

    PubMed  Google Scholar 

  2. Mandava P, Singaraju GS, Obili S, Nettam V, Vatturu S, Erugu S. Impact of self-esteem on the relationship between orthodontic treatment and the oral health-related quality of life in patients after orthodontic treatment - a systematic review. Med Pharm Rep. 2021;94(2):158–69.

    PubMed  PubMed Central  Google Scholar 

  3. Iranzo-Cortés JE, Montiel-Company JM, Bellot-Arcis C, Almerich-Torres T, Acevedo-Atala C, Ortolá-Siscar JC, et al. Factors related to the psychological impact of malocclusion in adolescents. Sci Rep. 2020;10(1):13471.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kavaliauskienė A, Šidlauskas A, Zaborskis A. Relationship Between Orthodontic Treatment Need and Oral Health-Related Quality of Life among 1-18-Year-Old Adolescents in Lithuania. Int J Environ Res Public Health. 2018;15(5):1012.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tristão SKPC, Magno MB, Pintor AVB, Christovam IFO, Ferreira DMTP, Maia LC, et al. Is there a relationship between malocclusion and bullying? A systematic review. Prog Orthod. 2020;21(1):26.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Fraga WS, Seixas VM, Santos JC, Paranhos LR, Cesar CP. Mouth breathing in children and its impact in dental malocclusion: a systematic review of observational studies. Minerva Stomatol. 2018;67(3):129–38.

    PubMed  Google Scholar 

  7. D’Onofrio L. Oral dysfunction as a cause of malocclusion. Orthod Craniofac Res. 2019;22(Suppl 1):43–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Grippaudo C, Paolantonio EG, Antonini G, Saulle R, La Torre G, Deli R. Association between oral habits, mouth breathing and malocclusion. Acta Otorhinolaryngol Ital. 2016;36(5):386–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Al-Anezi SA, Harradine NW. Quantifying plaque during orthodontic treatment. Angle Orthod. 2012;82(4):748–53.

    Article  PubMed  Google Scholar 

  10. Guo L, Feng Y, Guo HG, Liu BW, Zhang Y. Consequences of orthodontic treatment in malocclusion patients: clinical and microbial effects in adults and children. BMC Oral Health. 2016;16(1):112.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Julien KC, Buschang PH, Campbell PM. Prevalence of white spot lesion formation during orthodontic treatment. Angle Orthod. 2013;83(4):641–7.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Buschang PH, Chastain D, Keylor CL, Crosby D, Julien KC. Incidence of white spot lesions among patients treated with clear aligners and traditional braces. Angle Orthod. 2019;89(3):359–64.

    Article  PubMed  Google Scholar 

  13. Khoroushi M, Kachuie M. Prevention and Treatment of White Spot Lesions in Orthodontic Patients. Contemp Clin Dent. 2017;8(1):11–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Loe H, Silness J. PERIODONTAL DISEASE IN PREGNANCY I. PREVALENCE AND SEVERITY. Acta Odontol Scand. 1963;21:533–51.

    Article  CAS  PubMed  Google Scholar 

  15. Loe H, Theilade E, Jensen SB. EXPERIMENTAL GINGIVITIS IN MAN. J Periodontol. 1965;36:177–87.

    Article  CAS  Google Scholar 

  16. Zachrisson BU, Zachrisson S. Gingival condition associated with partial orthodontic treatment. Acta Odontol Scand. 1972;30(1):127–36.

    Article  CAS  PubMed  Google Scholar 

  17. Naranjo AA, Trivino ML, Jaramillo A, Betancourth M, Botero JE. Changes in the subgingival microbiota and periodontal parameters before and 3 months after bracket placement. Am J Orthod Dentofacial Orthop. 2006;130(3):275.e17-22.

    Article  PubMed  Google Scholar 

  18. Zachrisson BU, Alnaes L. Periodontal condition in orthodontically treated and untreated individuals. I. Loss of attachment, gingival pocket depth and clinical crown height. Angle Orthod. 1973;43(4):402–11.

    CAS  PubMed  Google Scholar 

  19. Zachrisson BU, Alnaes L. Periodontal condition in orthodontically treated and untreated individuals II. Alveolar bone loss: radiographic findings. Angle Orthod. 1974;44(1):48–55.

    CAS  PubMed  Google Scholar 

  20. Schatzle M, Faddy MJ, Cullinan MP, Seymour GJ, Lang NP, Burgin W, et al. The clinical course of chronic periodontitis: V Predictive factors in periodontal disease. J Clin Periodontol. 2009;36(5):365–71.

    Article  PubMed  Google Scholar 

  21. Schatzle M, Loe H, Burgin W, Anerud A, Boysen H, Lang NP. Clinical course of chronic periodontitis I. Role of gingivitis. J Clin Periodontol. 2003;30(10):887–901.

    Article  PubMed  Google Scholar 

  22. Schatzle M, Loe H, Lang NP, Burgin W, Anerud A, Boysen H. The clinical course of chronic periodontitis. J Clin Periodontol. 2004;31(12):1122–7.

    Article  PubMed  Google Scholar 

  23. Kim K, Heimisdottir K, Gebauer U, Persson GR. Clinical and microbiological findings at sites treated with orthodontic fixed appliances in adolescents. Am J Orthod Dentofacial Orthop. 2010;137(2):223–8.

    Article  PubMed  Google Scholar 

  24. Rego RO, Oliveira CA, dos Santos-Pinto A, Jordan SF, Zambon JJ, Cirelli JA, et al. Clinical and microbiological studies of children and adolescents receiving orthodontic treatment. Am J Dent. 2010;23(6):317–23.

    PubMed  Google Scholar 

  25. Freitas AO, Marquezan M, Nojima Mda C, Alviano DS, Maia LC. The influence of orthodontic fixed appliances on the oral microbiota: a systematic review. Dental Press J Orthod. 2014;19(2):46–55.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kim K, Jung WS, Cho S, Ahn SJ. Changes in salivary periodontal pathogens after orthodontic treatment: An in vivo prospective study. Angle Orthod. 2016;86(6):998–1003.

    Article  PubMed  Google Scholar 

  27. Ristic M, Vlahovic Svabic M, Sasic M, Zelic O. Effects of fixed orthodontic appliances on subgingival microflora. Int J Dent Hyg. 2008;6(2):129–36.

    Article  CAS  PubMed  Google Scholar 

  28. Ristic M, Vlahovic Svabic M, Sasic M, Zelic O. Clinical and microbiological effects of fixed orthodontic appliances on periodontal tissues in adolescents. Orthod Craniofac Res. 2007;10(4):187–95.

    Article  CAS  PubMed  Google Scholar 

  29. Liu KZ, Hynes A, Man A, Alsagheer A, Singer DL, Scott DA. Increased local matrix metalloproteinase-8 expression in the periodontal connective tissues of smokers with periodontal disease. Biochim Biophys Acta. 2006;1762(8):775–80.

    Article  CAS  PubMed  Google Scholar 

  30. de Morais EF, Pinheiro JC, Leite RB, Santos PPA, Barboza CAG, Freitas RA. Matrix metalloproteinase-8 levels in periodontal disease patients: A systematic review. J Periodontal Res. 2018;53(2):156–63.

    Article  PubMed  Google Scholar 

  31. McCulloch CA. Host enzymes in gingival crevicular fluid as diagnostic indicators of periodontitis. J Clin Periodontol. 1994;21(7):497–506.

    Article  CAS  PubMed  Google Scholar 

  32. Ehlers V, Callaway A, Hortig W, Kasaj A, Willershausen B. Clinical parameters and aMMP-8-concentrations in gingival crevicular fluid in pregnancy gingivitis. Clin Lab. 2013;59(5–6):605–11.

    CAS  PubMed  Google Scholar 

  33. Ehlers V, Helm S, Kasaj A, Willershausen B. The effect of Parodontax(R) on the MMP-8 concentration in gingivitis patients. Schweiz Monatsschr Zahnmed. 2011;121(11):1041–51.

    PubMed  Google Scholar 

  34. Surlin P, Rauten AM, Mogoanta L, Silosi I, Oprea B, Pirici D. Correlations between the gingival crevicular fluid MMP8 levels and gingival overgrowth in patients with fixed orthodontic devices. Rom J Morphol Embryol. 2010;51(3):515–9.

    PubMed  Google Scholar 

  35. Sioustis IA, Martu MA, Aminov L, Pavel M, Cianga P, Kappenberg-Nitescu DC, et al. Salivary Metalloproteinase-8 and Metalloproteinase-9 Evaluation in Patients Undergoing Fixed Orthodontic Treatment before and after Periodontal Therapy. Int J Environ Res Public Health. 2021;18(4).

  36. Ingman T, Apajalahti S, Mäntylä P, Savolainen P, Sorsa T. Matrix metalloproteinase-1 and -8 in gingival crevicular fluid during orthodontic tooth movement: a pilot study during 1 month of follow-up after fixed appliance activation. Eur J Orthod. 2005;27(2):202–7.

    Article  PubMed  Google Scholar 

  37. Apajalahti S, Sorsa T, Railavo S, Ingman T. The in vivo levels of matrix metalloproteinase-1 and -8 in gingival crevicular fluid during initial orthodontic tooth movement. J Dent Res. 2003;82(12):1018–22.

    Article  CAS  PubMed  Google Scholar 

  38. Barros SP, Williams R, Offenbacher S, Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol 2000. 2016;70(1):53–64.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Khiste SV, Ranganath V, Nichani AS, Rajani V. Critical analysis of biomarkers in the current periodontal practice. J Indian Soc Periodontol. 2011;15(2):104–10.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Morelli T, Stella M, Barros SP, Marchesan JT, Moss KL, Kim SJ, et al. Salivary biomarkers in a biofilm overgrowth model. J Periodontol. 2014;85(12):1770–8.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Sorsa T, Gursoy UK, Nwhator S, Hernandez M, Tervahartiala T, Leppilahti J, et al. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000. 2016;70(1):142–63.

    Article  PubMed  Google Scholar 

  42. Sorsa T, Nwhator SO, Sakellari D, Grigoriadis A, Umeizudike KA, Brandt E, et al. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases. Front Oral Health. 2022;3: 897115.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38(5):306–21.

    Article  CAS  PubMed  Google Scholar 

  44. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004;10(6):311–8.

    Article  CAS  PubMed  Google Scholar 

  45. Umeizudike K, Räisänen I, Gupta S, Nwhator S, Grigoriadis A, Sakellari D, et al. Active matrix metalloproteinase-8: A potential biomarker of oral systemic link. Clin Exp Dent Res. 2022;8(1):359–65.

    Article  PubMed  Google Scholar 

  46. Franco C, Patricia HR, Timo S, Claudia B, Marcela H. Matrix Metalloproteinases as Regulators of Periodontal Inflammation. Int J Mol Sci. 2017;18(2):440.

  47. Kinney JS, Morelli T, Oh M, Braun TM, Ramseier CA, Sugai JV, et al. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol. 2014;41(2):113–20.

    Article  CAS  PubMed  Google Scholar 

  48. Leppilahti JM, Tervahartiala T, Kautiainen H, Räisänen I, Ahonen MM, Uitto VJ, et al. Correlations between different protein species of oral rinse MMP-8 and patient-related factors. Clin Exp Dent Res. 2023;9(6):1021–33. https://doi.org/10.1002/cre2.803.

  49. Sorsa T, Sahni V, Buduneli N, Gupta S, Räisänen IT, Golub LM, et al. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic. Expert Rev Proteomics. 2021;18(8):707–17.

    Article  CAS  PubMed  Google Scholar 

  50. Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane DF, et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol. 1996;23(12):1127–32.

    Article  CAS  PubMed  Google Scholar 

  51. Sorsa T, Mäntylä P, Rönkä H, Kallio P, Kallis GB, Lundqvist C, et al. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci. 1999;878:130–40.

    Article  CAS  PubMed  Google Scholar 

  52. Lähteenmäki H, Umeizudike KA, Heikkinen AM, Räisänen IT, Rathnayake N, Johannsen G, et al. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting. Diagnostics (Basel). 2020;10(8):562.

  53. Al-Majid A, Alassiri S, Rathnayake N, Tervahartiala T, Gieselmann DR, Sorsa T. Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases. Int J Dent. 2018;2018:7891323.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Xanthopoulou V, Räisänen I, Sorsa T, Sakellari D. Active MMP-8 as a Biomarker of Peri-implant Health or Disease. Eur J Dent. 2023;17(3):924–8.

    Article  PubMed  Google Scholar 

  55. Lähteenmäki H, Tervahartiala T, Räisänen IT, Pärnänen P, Mauramo M, Gupta S, et al. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis. Clin Exp Dent Res. 2022;8(2):485–96.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Luchian I, Goriuc A, Sandu D, Covasa M. The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes. Int J Mol Sci. 2022;23(3):1806.

  57. Silness J, Loe H. PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand. 1964;22:121–35.

    Article  CAS  PubMed  Google Scholar 

  58. Silness J, Loe H. Periodontal disease in pregnancy. 3. Response to local treatment. Acta Odontol Scand. 1966;24(6):747–59.

    Article  CAS  PubMed  Google Scholar 

  59. O’Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972;43(1):38.

    Article  CAS  PubMed  Google Scholar 

  60. Quigley GA, Hein JW. Comparative cleansing efficiency of manual and power brushing. J Am Dent Assoc. 1962;65:26–9.

    Article  CAS  PubMed  Google Scholar 

  61. Erbe C, Klees V, Braunbeck F, Ferrari-Peron P, Ccahuana-Vasquez RA, Timm H, et al. Comparative assessment of plaque removal and motivation between a manual toothbrush and an interactive power toothbrush in adolescents with fixed orthodontic appliances: A single-center, examiner-blind randomized controlled trial. Am J Orthod Dentofacial Orthop. 2019;155(4):462–72.

    Article  PubMed  Google Scholar 

  62. Erbe C, Klees V, Ferrari-Peron P, Ccahuana-Vasquez RA, Timm H, Grender J, et al. A comparative assessment of plaque removal and toothbrushing compliance between a manual and an interactive power toothbrush among adolescents: a single-center, single-blind randomized controlled trial. BMC Oral Health. 2018;18(1):130.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Kossack C, Jost-Brinkmann PG. Plaque and gingivitis reduction in patients undergoing orthodontic treatment with fixed appliances-comparison of toothbrushes and interdental cleaning aids. A 6-month clinical single-blind trial. J Orofac Orthop. 2005;66(1):20–38.

    Article  PubMed  Google Scholar 

  64. Rams TE, Oler J, Listgarten MA, Slots J. Utility of Ramfjord index teeth to assess periodontal disease progression in longitudinal studies. J Clin Periodontol. 1993;20(2):147–50.

    Article  CAS  PubMed  Google Scholar 

  65. Schlagenhauf U, Jakob L, Eigenthaler M, Segerer S, Jockel-Schneider Y, Rehn M. Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT. J Clin Periodontol. 2016;43(11):948–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Fleiss JL, Park MH, Chilton NW, Alman JE, Feldman RS, Chauncey HH. Representativeness of the “Ramfjord teeth” for epidemiologic studies of gingivitis and periodontitis. Community Dent Oral Epidemiol. 1987;15(4):221–4.

    Article  CAS  PubMed  Google Scholar 

  67. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol. 2018;45(Suppl 20):S149–61.

    PubMed  Google Scholar 

  68. Sorsa T, Alassiri S, Grigoriadis A, Räisänen IT, Pärnänen P, Nwhator SO, et al. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification. Diagnostics (Basel). 2020;10(2):61.

  69. Deng K, Pelekos G, Jin L, Tonetti MS. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease. J Clin Periodontol. 2021;48(8):1051–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Thornberg MJ, Riolo CS, Bayirli B, Riolo ML, Van Tubergen EA, Kulbersh R. Periodontal pathogen levels in adolescents before, during, and after fixed orthodontic appliance therapy. Am J Orthod Dentofacial Orthop. 2009;135(1):95–8.

    Article  PubMed  Google Scholar 

  71. Liu H, Sun J, Dong Y, Lu H, Zhou H, Hansen BF, et al. Periodontal health and relative quantity of subgingival Porphyromonas gingivalis during orthodontic treatment. Angle Orthod. 2011;81(4):609–15.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Cerroni S, Pasquantonio G, Condo R, Cerroni L. Orthodontic Fixed Appliance and Periodontal Status: An Updated Systematic Review. Open Dent J. 2018;12:614–22.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Gomes SC, Varela CC, da Veiga SL, Rosing CK, Oppermann RV. Periodontal conditions in subjects following orthodontic therapy. A preliminary study Eur J Orthod. 2007;29(5):477–81.

    Article  PubMed  Google Scholar 

  74. Bildt MM, Bloemen M, Kuijpers-Jagtman AM, Von den Hoff JW. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in gingival crevicular fluid during orthodontic tooth movement. Eur J Orthod. 2009;31(5):529–35.

    Article  CAS  PubMed  Google Scholar 

  75. Schroder A, Bauer K, Spanier G, Proff P, Wolf M, Kirschneck C. Expression kinetics of human periodontal ligament fibroblasts in the early phases of orthodontic tooth movement. J Orofac Orthop. 2018;79(5):337–51.

    Article  PubMed  Google Scholar 

  76. Avellan NL, Sorsa T, Tervahartiala T, Forster C, Kemppainen P. Experimental tooth pain elevates substance P and matrix metalloproteinase-8 levels in human gingival crevice fluid. Acta Odontol Scand. 2008;66(1):18–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Open Access funding enabled and organized by Projekt DEAL. No funding was obtained for this study.

Author information

Authors and Affiliations

Authors

Contributions

PFP was the principal investigator, recruited all patients for the study, conducted the study visits and was a major contributor in writing this manuscript. CE, WE, AM also participated in the study design and contributed in writing the manuscript. IS performed all the statistical analysis of this study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Priscila Ferrari Peron.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of the dental medical association Rheiland-Pfalz, Germany (process no. 837.340.12 (8441-F)), and followed the guidelines of Good Clinical Practices. A written informed consent was obtained from all participants and their guardian prior data collection.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peron, P.F., Wehrbein, H., Mundethu, A. et al. Clinical parameters and inflammatory biomarkers among patients with multibracket appliances: a prospective clinical trial. BMC Oral Health 24, 308 (2024). https://doi.org/10.1186/s12903-024-03995-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12903-024-03995-3

Keywords